Kymera Therapeutics Announces Results From Its Phase 1 Study Of KT-621 In Healthy Japanese Adults Were Shared At The Japanese Dermatological Association Annual Meeting, June 11-14

Loading news article.

Kymera Therapeutics Announces Results From Its Phase 1 Study Of KT-621 In Healthy Japanese Adults Were Shared At The Japanese Dermatological Association Annual Meeting, June 11-14 | WAPE

Kymera Therapeutics Announces Results From Its Phase 1 Study Of KT-621 In Healthy Japanese Adults Were Shared At The Japanese Dermatological Association Annual Meeting, June 11-14

Article summary

Related companies

Comments —